The plasma Epstein–Barr virus DNA level guides precision treatment for nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: a large population-based cohort study from an endemic area

The plasma Epstein–Barr virus DNA level guides precision treatment for nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: a large population-based cohort study from an endemic area

Background: In the intensity-modulated radiotherapy (IMRT) era, the survival benefit of concurrent chemotherapy for locoregionally advanced nasopharyngeal carcinoma (LA-NPC) remains undetermined. This study aimed to evaluate the benefits of IMRT with concurrent chemotherapy compared with IMRT alone...

Full description

Bibliographic Details
Main Authors:	Hu Liang, Xing Lv, Lin Wang, Yi-Shan Wu, Rui Sun, Yan-Fang Ye, Liang-Ru Ke, Qin Yang, Ya-Hui Yu, Wen-Ze Qiu, Guo-Ying Liu, Xin-Jun Huang, Wang-Zhong Li, Shu-Hui Lv, Xiang Guo, Yan-Qun Xiang, Wei-Xiong Xia
Format:	Article
Language:	English
Published:	SAGE Publishing 2018-07-01
Series:	Therapeutic Advances in Medical Oncology
Online Access:	https://doi.org/10.1177/1758835918782331

Similar Items

Clinical Implications of Plasma Epstein–Barr Virus DNA in Children and Adolescent Nasopharyngeal Carcinoma Patients Receiving Intensity-Modulated Radiotherapy
by: Wenze Qiu, et al.
Published: (2020-03-01)

Role of Epstein-Barr virus in the development of nasopharyngeal carcinoma
by: Zhang Hui, et al.
Published: (2017-06-01)

The role of Epstein–Barr virus in nasopharyngeal carcinoma
by: Zhi Yi Su, et al.
Published: (2023-02-01)

Plasma Circulating Tumor Epstein–Barr Virus for the Surveillance of Cancer Progression in Bone-Only Metastatic Nasopharyngeal Carcinoma
by: Guo-Ying Liu, et al.
Published: (2022-06-01)

A retrospective study of 606 cases of nasopharyngeal carcinoma with or without oropharyngeal candidiasis during radiotherapy.
by: Wen-Ze Qiu, et al.
Published: (2017-01-01)

A model to predict the risk of lethal nasopharyngeal necrosis after re-irradiation with intensity-modulated radiotherapy in nasopharyngeal carcinoma patients
by: Ya-Hui Yu, et al.
Published: (2016-06-01)

Link of Nasopharyngeal Carcinoma and Epstein-Barr Virus
by: Sugiyanto Sugiyanto, et al.
Published: (2018-10-01)

Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma
by: Pok Man Hau, et al.
Published: (2020-05-01)

Epstein-Barr virus DNA seropositivity links distinct tumoral heterogeneity and immune landscape in nasopharyngeal carcinoma
by: Wangzhong Li, et al.
Published: (2023-02-01)

Liquid biopsy posttreatment surveillance in endemic nasopharyngeal carcinoma: a cost-effective strategy to integrate circulating cell-free Epstein-Barr virus DNA
by: Chen-Fei Wu, et al.
Published: (2021-08-01)

Detection of epstein - barr virus (EBV) in nasopharyngeal cancer.
by: Seow, Heng Fong
Published: (2007)

Epstein-Barr DNA in advanced pediatric nasopharyngeal cancer
by: Marlinda Adham, et al.
Published: (2021-09-01)

The evolution of Epstein-Barr virus detection in nasopharyngeal carcinoma
by: You Quan Li, et al.
Published: (2018-03-01)

Exploring the Optimal Chemotherapy Strategy for Locoregionally Advanced Children and Adolescent Nasopharyngeal Carcinoma Based on Pretreatment Epstein-Barr Virus DNA Level in the Era of Intensity Modulated Radiotherapy
by: Ziyi Zeng, et al.
Published: (2021-01-01)

Nasopharyngeal Carcinoma Progression: Accumulating Genomic Instability and Persistent Epstein–Barr Virus Infection
by: Xue Liu, et al.
Published: (2022-08-01)

Oral Microbiota Alteration and Roles in Epstein-Barr Virus Reactivation in Nasopharyngeal Carcinoma
by: Ying Liao, et al.
Published: (2023-02-01)

Natural Variations in BRLF1 Promoter Contribute to the Elevated Reactivation Level of Epstein-Barr Virus in Endemic Areas of Nasopharyngeal CarcinomaResearch in context
by: Jiang-Bo Zhang, et al.
Published: (2018-11-01)

Treatment outcomes of Epstein-Barr virus-associated nasopharyngeal carcinoma
by: Santhuri Viranna, et al.
Published: (2024-01-01)

Nasopharyngeal Carcinoma: The Role of the EGFR in Epstein–Barr Virus Infection
by: Xintong Peng, et al.
Published: (2021-08-01)

Stochastic profile of Epstein-Barr virus in nasopharyngeal carcinoma settings
by: Cordeiro Marcos Tadeu Andrade, et al.
Published: (2019-01-01)

Tumor residue in patients with stage II–IVA nasopharyngeal carcinoma who received intensity-modulated radiation therapy: development and validation of a prediction nomogram integrating postradiotherapy plasma Epstein–Barr virus deoxyribonucleic acid, clinical stage, and radiotherapy dose
by: Ying-Ying Huang, et al.
Published: (2023-05-01)

Sequence analysis of the Epstein-Barr virus (EBV) BRLF1 gene in nasopharyngeal and gastric carcinomas
by: Jing Yongzheng, et al.
Published: (2010-11-01)

The diagnostic and prognostic values of plasma Epstein-Barr virus DNA for residual cervical lymphadenopathy in nasopharyngeal carcinoma patients: a retrospective study
by: Sai-Lan Liu, et al.
Published: (2019-03-01)

Patterns of failure and prognosis in nasopharyngeal carcinoma according to Epstein-Barr virus DNA status
by: Lin-Feng Guo, et al.
Published: (2025-02-01)

Epstein-Barr viral latent and early antigen serology in nasopharyngeal carcinoma
by: Tan, Timothy Ter Ming.
Published: (2008)

Comparison of Circulating Tumour Cells and Circulating Cell-Free Epstein-Barr Virus DNA in Patients with Nasopharyngeal Carcinoma Undergoing Radiotherapy
by: Jess Honganh Vo, et al.
Published: (2016-12-01)

Occipital lymph node metastasis from nasopharyngeal carcinoma: a special case report and literature review
by: Jing Yang, et al.
Published: (2016-01-01)

Competitive Endogenous RNA Landscape in Epstein-Barr Virus Associated Nasopharyngeal Carcinoma
by: Xiandong Lin, et al.
Published: (2021-11-01)

Precision radiotherapy for nasopharyngeal carcinoma
by: Zhenyu Zhang, et al.
Published: (2024-03-01)

Age-dependent changes of gender disparities in nasopharyngeal carcinoma survival
by: Wang-Zhong Li, et al.
Published: (2021-01-01)

Prospective evaluation of the relevance of Epstein–Barr virus antibodies for early detection of nasopharyngeal carcinoma in Chinese adults
by: Yang, L, et al.
Published: (2024)

Nasopharyngeal Epstein-Barr Virus Load: An Efficient Supplementary Method for Population-Based Nasopharyngeal Carcinoma Screening.
by: Yufeng Chen, et al.
Published: (2015-01-01)

Epstein–Barr virus-associated poorly differentiated nasopharyngeal adenocarcinoma: a case report and literature review
by: Shuai Zhang, et al.
Published: (2023-05-01)

Impact of Epstein-Barr virus and CD lymphocytes on the prognosis of patients with advanced nasopharyngeal carcinoma
by: Fangchu Liu, et al.
Published: (2025-02-01)

Prognostic Value of Oral Epstein–Barr Virus DNA Load in Locoregionally Advanced Nasopharyngeal Carcinoma
by: Yong-Qiao He, et al.
Published: (2022-01-01)

Association of Epstein-Barr virus infection with peripheral immune parameters and clinical outcome in advanced nasopharyngeal carcinoma
by: Dan Tao, et al.
Published: (2020-12-01)

Markers of Epstein–Barr virus in clinical assessment of Russian patients with nasopharyngeal cancer
by: K. V. Smirnova, et al.
Published: (2021-11-01)

Characterization of Epstein-Barr virus miRNAome in nasopharyngeal carcinoma by deep sequencing.
by: Shu-Jen Chen, et al.
Published: (2010-09-01)

Epstein-Barr Virus Latent Membrane Protein-1 Expression in Nasopharyngeal Carcinoma
by: Valerie E. Salano, et al.
Published: (2021-12-01)

Molecular Detection of Epstein - Barr virus in Nasopharyngeal Carcinoma among Sudanese population
by: Ali Edris, et al.
Published: (2016-11-01)